Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Chueca

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
International Journal of Molecular Sciences|February 11, 2023
Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of AndalusiaJavier Perez-Florido, Carlos S Casimiro-Soriguer, Francisco Ortuño, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2026
Comparative activity of established versus new-generation β-lactams against AmpC-hyperproducing clinical isolates of Enterobacter cloacae complex and Klebsiella aerogenes: a multicentre studyÁngel Rodríguez-Villodres, Jesús Rodríguez-Lozano, Alba Mir-Cros, et al.
Journal of Hepatology|July 8, 2019
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real worldAna Belén Pérez, Natalia Chueca, Miguel García-Deltoro, et al.
BMC Cancer|May 26, 2019
Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical studyJulio Plaza-Díaz, Ana I Álvarez-Mercado, Carmen M Ruiz-Marín, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2017
Hepatitis C virus core antigen in the management of patients treated with new direct-acting antiviralsJuan Carlos Alados Arboledas, Inmaculada Pavón Guerrero, María José Blanco Rodríguez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Sample pooling for SARS-CoV-2 RT-PCR screeningAdolfo de Salazar, Antonio Aguilera, Rocio Trastoy, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2019
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Alvarez, Paz Casas, Adolfo de Salazar, et al.
Plos One|August 31, 2019
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohortAna Belén Pérez, Natalia Chueca, Juan Macías, et al.
Human Molecular Genetics|July 18, 2022
Detailed stratified GWAS analysis for severe COVID-19 in four European populationsFrauke Degenhardt, David Ellinghaus, Simonas Juzenas, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
International Journal of Molecular Sciences|February 11, 2023
Detection of High Level of Co-Infection and the Emergence of Novel SARS CoV-2 Delta-Omicron and Omicron-Omicron Recombinants in the Epidemiological Surveillance of AndalusiaJavier Perez-Florido, Carlos S Casimiro-Soriguer, Francisco Ortuño, et al.
The Journal of Antimicrobial Chemotherapy|February 6, 2026
Comparative activity of established versus new-generation β-lactams against AmpC-hyperproducing clinical isolates of Enterobacter cloacae complex and Klebsiella aerogenes: a multicentre studyÁngel Rodríguez-Villodres, Jesús Rodríguez-Lozano, Alba Mir-Cros, et al.
Journal of Hepatology|July 8, 2019
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real worldAna Belén Pérez, Natalia Chueca, Miguel García-Deltoro, et al.
BMC Cancer|May 26, 2019
Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical studyJulio Plaza-Díaz, Ana I Álvarez-Mercado, Carmen M Ruiz-Marín, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2017
Hepatitis C virus core antigen in the management of patients treated with new direct-acting antiviralsJuan Carlos Alados Arboledas, Inmaculada Pavón Guerrero, María José Blanco Rodríguez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2020
Sample pooling for SARS-CoV-2 RT-PCR screeningAdolfo de Salazar, Antonio Aguilera, Rocio Trastoy, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2019
Surveillance of transmitted drug resistance to integrase inhibitors in Spain: implications for clinical practiceMarta Alvarez, Paz Casas, Adolfo de Salazar, et al.
Plos One|August 31, 2019
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohortAna Belén Pérez, Natalia Chueca, Juan Macías, et al.
Human Molecular Genetics|July 18, 2022
Detailed stratified GWAS analysis for severe COVID-19 in four European populationsFrauke Degenhardt, David Ellinghaus, Simonas Juzenas, et al.
Pageof 7